New treatment working on COVID-19 virus

MELBOURNE: Those infected with the COVID-19 virus have been successfully treated with malaria and HIV drugs in a secret trial.

Fifty Australian hospitals will be given HIV medication Kaletra and malaria treatment hydroxychloroquine in a clinical trial which promises to “cure” the virus.

Curing the virus means there will be no trace of it in the body.

Prof Paterson, director of the university’s Centre for Clinical Research, yesterday were given to the Australian patients infected with COVID-19 all recovered completely without any sign of the virus left in their bodies.

It comes as 28 new cases of coronavirus were confirmed in Victoria yesterday, bringing the total number to 178 in the state. The new cases include 18 men and 10 women, aged from mid-teens to late 60s. Six people are still in hospital with a coronavirus diagnosis.

The media also revealed the federal government will provide researchers with $13 million to fast-track coronavirus treatments.

The cash injection from the Medical Research Future Fund includes $8 million to develop antiviral therapies for people who contract the virus.

Up to 10 treatments are expected to be tested, with the most promising options pushed rapidly through human clinical trials to regulatory approval and commercialisation.

Another $5 million will be spent on clinical trials to help patients with severe acute respiratory distress, which can be fatal, especially among older people and those with compromised immune systems and chronic illnesses.

Health Minister Greg Hunt said Australian researchers had “outstanding capacity to contribute to global efforts to control the outbreak and save lives”. He said the funding was part of the government’s $2.4 billion coronavirus national health plan.

“Australia has produced some of the world’s best medical research,” Mr Hunt said.

Prof Paterson is heading the Australian clinical trial of a COVID-19 treatment combining HIV medication Kaletra and malaria medication Hydroxychloroquine.

The combination treatment was found to kill off coronavirus in test tubes and had cleared the virus in a handful of Australian patients, he said.

“Prior to the clinical trials going ahead, the medications were given to some of the first Australian patients infected with COVID-19, and all have completely recovered without any trace of the virus left in their system,” he said.

The further trials across 50 hospitals will compare the effectiveness of the malaria drug on its own against the HIV drug on its own. Other patients will be given the medications in combination.

“This will enable us to test the first wave of Australian patients and gain real-world experience with this treatment, especially since we expect ongoing infections to continue for many months,” he said. “If we can obtain the best possible information now, then we can quickly treat subsequent patients down the track.”

Prof Paterson said the drugs to be used in the clinical trials could be administered orally as tablets.

Australia’s medicines regulator says it is ready to fast track the approval of any vaccines or treatments to beat the coronavirus. About 35 companies and academic institutions are working to create a vaccine, and four are already testing in animals.

Researchers at Queensland University are hoping to begin animal trials of its COVID-19 vaccine next month and Griffith University announced on Thursday it has signed a memorandum of understanding with Queensland-based Luina Bio to work on a vaccine.

However, it could be 12-18 months before a vaccine is ready. Extensive clinical trials are necessary as ferrets given a vaccine for the 2003 SARS outbreak suffered a more serious form of the illness after vaccination.

In relation to the multimillion-dollar grant to researchers, Mr Hunt said: “This is another example of us contributing to address important health challenges for Australians and for the global population.”

Researchers will be able to apply for the grants from next week.